YAP1 is a key regulator of EWS::FLI1-dependent malignant transformation upon IGF-1 mediated reprogramming of bone mesenchymal stem cells
H. Kovar, R. Noorizadeh, B. Sax, T. Javaheri, B. Radic Sarikas, V. Fock, M. Kauer, A. Bykov, V. Suresh, M. Schlederer, L. Kenner, G. Weber, W. Mikulits, F. Halbritter, R. Moriggl
The paper shows that IGF-1 reprograms bone mesenchymal stem cells in EWS::FLI1-mutant mice, leading to tumor formation, with Yap1 playing a central role, and suggests combined IGF-1R and YAP/TEAD inhibition as a potential treatment.
bioRxiv · Jul 15, 2024Cancer Biology